Antimalarial Drug Resistance With Assessment of Transmission Blocking Activity

NCT01849640 · clinicaltrials.gov ↗

NA

Phase

SUSPENDED

Status

150

Enrollment

OTHER_GOV

Sponsor class

Stopped Poor efficacy of DHA-piperaquine due to likely drug resistance.

Conditions

Uncomplicated Plasmodium Falciparum Malaria

Interventions

DRUG: DHA-piperaquine and Primaquine

Sponsor

David Saunders

Collaborators

[object Object]
[object Object]
[object Object]